Evidence map›Paper›PMID 22586419›Full record

ArticleFrontiers in neurology2012

Behavioral and psychological symptoms of dementia.

J Cerejeira, L Lagarto, E B Mukaetova-Ladinska

4 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 511 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
511citing papers in PubMed, 14 pooled it
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03354819 nacompletednot on this mapstarted 2017, after this paper: background citation

Effects of a Modified Mindfulness-based Cognitive Therapy for Family Caregivers of People With Dementia in Stress Reduction: A Randomized Controlled Trial

TypeinterventionalSponsorThe Hong Kong Polytechnic UniversityRan2017 to 2019Enrolled113ConditionsCarer Stress Syndrome, DementiaArmsModified MBCT, SIRE on dementia
NCT04436081 phase2recruitingnot on this mapstarted 2021, after this paper: background citation

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

TypeinterventionalSponsorEastern Virginia Medical SchoolRan2021 to 2024Enrolled40ConditionsAlzheimer Disease, Dementia, Major Neurocognitive Disorder With Aggressive BehaviorArmsTHC-free CBD Oil, Placebo
NCT05808530 nacompletednot on this mapstarted 2023, after this paper: background citation

The Effect of Cognitive Stimulation Therapy on Apathy, Loneliness, Anxiety and Activities of Daily Living in Elderly Individuals Diagnosed With Alzheimer's

TypeinterventionalSponsorHasan Kalyoncu UniversityRan2023 to 2023Enrolled56ConditionsAlzheimer Disease 10, Dementia, Apathy, AnxietyArmsCognitive Stimulation Therapy
NCT06221202 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Stories in the Moment: Dance Program for People Living With Dementia

TypeinterventionalSponsorDanceStream ProjectsRan2023 to 2024Enrolled72ConditionsDementia, Mild Cognitive Impairment, Alzheimer Disease, Lewy Body DiseaseArmsStories in the Moment Dance Program - Online
3 · Its place in the literature

Who cites it

511 citing papers in PubMed, 14 syntheses or guidelines pooled it, 1,366 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Facial Emotion Recognition Ability May Improve in Alzheimer Disease: A Pilot Study.Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2026
    Trial
  18. Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  19. Trial
  20. Trial

451 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

J CerejeiraServiço de Psiquiatria, Centro Hospitalar Psiquiátrico de Coimbra Coimbra, Portugal.
L Lagarto
E B Mukaetova-Ladinska
Hospitais da Universidade de Coimbra · PTNewcastle Hospitals - Campus for Ageing and Vitality · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Behavioral and psychological symptoms of dementia (BPSD), also known as neuropsychiatric symptoms, represent a heterogeneous group of non-cognitive symptoms and behaviors occurring in subjects with dementia. BPSD constitute a major component of the dementia syndrome irrespective of its subtype. They are as clinically relevant as cognitive symptoms as they strongly correlate with the degree of functional and cognitive impairment. BPSD include agitation, aberrant motor behavior, anxiety, elation, irritability, depression, apathy, disinhibition, delusions, hallucinations, and sleep or appetite changes. It is estimated that BPSD affect up to 90% of all dementia subjects over the course of their illness, and is independently associated with poor outcomes, including distress among patients and caregivers, long-term hospitalization, misuse of medication, and increased health care costs. Although these symptoms can be present individually it is more common that various psychopathological features co-occur simultaneously in the same patient. Thus, categorization of BPSD in clusters taking into account their natural course, prognosis, and treatment response may be useful in the clinical practice. The pathogenesis of BPSD has not been clearly delineated but it is probably the result of a complex interplay of psychological, social, and biological factors. Recent studies have emphasized the role of neurochemical, neuropathological, and genetic factors underlying the clinical manifestations of BPSD. A high degree of clinical expertise is crucial to appropriately recognize and manage the neuropsychiatric symptoms in a patient with dementia. Combination of non-pharmacological and careful use of pharmacological interventions is the recommended therapeutic for managing BPSD. Given the modest efficacy of current strategies, there is an urgent need to identify novel pharmacological targets and develop new non-pharmacological approaches to improve the adverse outcomes associated with BPSD.

Indexed as

Alzheimer’s diseasebehavioral and psychological symptomsdementianeuropsychiatric symptoms

Identifiers

PMID22586419
PMCPMC3345875
OpenAlexW2120296399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.